Miss Georgia McCaughan

Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, vol. 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072

Bishop DC; Clancy LE; Simms R; Burgess J; Mathew G; Moezzi L; Street JA; Sutrave G; Atkins E; McGuire HM; Gloss BS; Lee K; Jiang W; Maddock K; McCaughan G; Avdic S; Antonenas V; O'Brien TA; Shaw PJ; Irving DO; Gottlieb DJ; Blyth E; Micklethwaite KP, 2021, 'Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells', Blood, vol. 138, pp. 1504 - 1509, http://dx.doi.org/10.1182/blood.2021010813

Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', Blood, vol. 138, pp. 4940 - 4940, http://dx.doi.org/10.1182/blood-2021-154028

Chai KL; Wellard C; Moore EM; Augustson B; Bapat A; Blacklock HA; Cooke RE; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; King T; McCaughan GJ; Mollee P; Morrissey O; Murphy NE; Quach H; Tan XN; Wong K; Spencer A; Wood EM; McQuilten Z, 2021, 'Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)', Blood, vol. 138, pp. 4757 - 4757, http://dx.doi.org/10.1182/blood-2021-147622

Hung D; Lenton D; Eslick R; Blennerhassett R; Joshi M; McCaughan G; Day S; Wright D, 2021, 'Chromosome microarray characterisation of chromosome arm 12p loss associated with complex molecular karyotype and recurrent adverse cytogenetic markers in multiple myeloma', Genes Chromosomes and Cancer, vol. 60, pp. 668 - 677, http://dx.doi.org/10.1002/gcc.22975

McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N, 2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, vol. 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247

McCaughan G; Jarvis S; Joseph J, 2021, 'Abnormal coagulation profiles in monoclonal gammopathy of undetermined significance: a case series', Pathology, vol. 53, pp. 798 - 800, http://dx.doi.org/10.1016/j.pathol.2020.11.005

McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, vol. 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8

McCaughan GJ; Tran S; Durrant S; Harrison S; Morton J; Horvath N; Spencer A; Kerridge IH; Ke Er JA; Barge L; Bryant A; Filshie R; Choong E; Lai HC; Tiley C; Mills A; Butler A; Moore J; Hertzberg M; Kennedy G; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee C; Kalff A; Xia W; Hamad N, 2021, 'Trends and Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, vol. 27, pp. S399 - S401, http://dx.doi.org/10.1016/s2666-6367(21)00515-7

McCaughan GJ; Verma A; Ling S; Lavee O; Moore JJ; Bryant A, 2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, vol. 56, pp. 738 - 740, http://dx.doi.org/10.1038/s41409-020-01086-9

Mills G; Tang C; Di Ciaccio PR; Chadwick VL; Withers B; Lavee O; Milliken S; Perram J; McCaughan GJ; Hamad N, 2021, 'Systematic Omission of Pregnant and Lactating Women from Malignant Haematology Trials Perpetuates a Cycle of Exclusion, Data Shortage and Disadvantage', Blood, vol. 138, pp. 3050 - 3050, http://dx.doi.org/10.1182/blood-2021-149354

Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N, 2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, vol. 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859

McCaughan GJ; Crowther HJ; Chen V; Chunilal SD; Merriman E; Bortz H; Young L; Tran HA; Yuen HLA; Curnow J, 2020, 'Australian and New Zealand Registry of Anticoagulation in the Obese: Prescribing Patterns, Drug Levels and Patient Outcomes', Blood, vol. 136, pp. 21 - 21, http://dx.doi.org/10.1182/blood-2020-143150

McCaughan GJ; Tran S; Durrant S; Harrison SJ; Morton J; Horvath N; Spencer A; Kerridge IH; Er JAK; Barge L; Bryant A; Filshie RJ; Choong E; Lai HC; Tiley C; Mills AK; Butler A; Moore J; Hertzberg M; Kennedy GA; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee CH; Kalff A; Xia W; Hamad N, 2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Blood, vol. 136, pp. 11 - 12, http://dx.doi.org/10.1182/blood-2020-138991

McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', Blood, vol. 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269

Blennerhassett R; McCaughan G; Tegg E, 2019, 'Massive Splenomegaly, An Unexpected Diagnosis', Pathology, vol. 51, pp. S41 - S41, http://dx.doi.org/10.1016/j.pathol.2018.12.091

Blennerhassett R; McCaughan G; Tegg E, 2018, 'An unexpected diagnosis: leukaemic presentation of blastic plasmacytoid dendritic cell neoplasm with massive splenomegaly', Pathology, vol. 50, pp. 773 - 775, http://dx.doi.org/10.1016/j.pathol.2018.05.007

Favaloro EJ; McCaughan G; Mohammed S; Lau KKE; Gemmell R; Cavanaugh L; Donikian D; Kondo M; Brighton T; Pasalic L, 2018, 'HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia', Pathology, vol. 50, pp. 426 - 436, http://dx.doi.org/10.1016/j.pathol.2017.11.089

Favaloro EJ; McCaughan GJB; Mohammed S; Pasalic L, 2018, 'Anticoagulation therapy in Australia', Annals of Blood, vol. 3, pp. 48 - 48, http://dx.doi.org/10.21037/aob.2018.12.02

McCaughan GJB; Favaloro EJ; Pasalic L; Curnow J, 2018, 'Anticoagulation at the extremes of body weight: choices and dosing', Expert Review of Hematology, vol. 11, pp. 817 - 828, http://dx.doi.org/10.1080/17474086.2018.1517040

Favaloro EJ; McCaughan G; Pasalic L, 2017, 'Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update', Pathology, vol. 49, pp. 346 - 355, http://dx.doi.org/10.1016/j.pathol.2017.02.005

McCaughan G; Massey J; Sutton I; Curnow J, 2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, vol. 2017, http://dx.doi.org/10.1136/bcr-2017-223016

McCaughan GJB; Fulham MJ; Mahar A; Soper J; Hong AM; Stalley PD; Tattersall MHN; Bhadri VA, 2016, 'Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma', Journal of Hematology and Oncology, vol. 9, http://dx.doi.org/10.1186/s13045-016-0278-x

Kiely BE; McCaughan G; Christodoulou S; Beale PJ; Grimison P; Trotman J; Tattersall MHN; Stockler MR, 2013, 'Using scenarios to explain life expectancy in advanced cancer: Attitudes of people with a cancer experience', Supportive Care in Cancer, vol. 21, pp. 369 - 376, http://dx.doi.org/10.1007/s00520-012-1526-4

Mccaughan GJ; Blinman PL; Boyer MJ; Stockler MR, 2013, 'Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer', Internal Medicine Journal, vol. 43, pp. 424 - 429, http://dx.doi.org/10.1111/j.1445-5994.2012.02846.x

Stockler MR; Kiely BE; McCaughan GJ; Christodoulou S; Beale PJ; Trotman J; Grimison P; Tattersall MHN, 2012, 'Using scenarios to explain survival time: Attitudes of people with a cancer experience.', Journal of Clinical Oncology, vol. 30, pp. 9126 - 9126, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9126

Quach H; Lasica M; Routledge D; Kalff A; Lim A; Low M; Estell JA; Sidiqi MH; Campbell P; Eek RW; Lai HC; McCaughan GJ; D'Rozario J; Browlett P; Rajagopal R; Heenan J; Murphy NE; Renwick W; Huan G; Mollee P, 2021, 'A randomized, open-label, phase 3 study of low-dose selinexor and lenalidomide (Len) versus len maintenance post autologous stem cell transplant (ASCT) for newly diagnosed multiple myeloma (NDMM): ALLG MM23, Sealand.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.TPS8055

Kiely BE; McCaughan G; Christodoulou S; Tattersall MHN; Beale P; Grimison P; Stockler MR, 2011, 'P5-15-02: Patients' Views about How Oncologists Should Explain Prognosis in Advanced Cancer.', in Poster Session Abstracts, American Association for Cancer Research, presented at Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX, http://dx.doi.org/10.1158/0008-5472.sabcs11-p5-15-02